JJJasper Therapeutics, Inc.
0.0868USDR
−0.0004−0.46%
Last update at May 14, 14:30 GMT
USD
No trades
−5.2500 USD
−71.27 M USD
0.00 USD
11.78 M
About Jasper Therapeutics, Inc.
Sector
Industry
CEO
Ronald A. Martell
Website
Headquarters
Redwood City
Founded
2018
FIGI
BBG00RBFC714
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−28.00 M
−21.00 M
−14.00 M
−7.00 M
0.00
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
−24.00 M
−18.00 M
−12.00 M
−6.00 M
0.00
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
−24.00 M
−18.00 M
−12.00 M
−6.00 M
0.00
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−40.00 M
0.00
40.00 M
80.00 M
120.00 M
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
Displays a symbol's price movements over previous years to identify recurring trends.